EXOJUV

Product Description

EXOJUV represents an advanced exosome-based regeneration solution containing 6 billion extracellular vesicles per dose. This innovative formulation delivers anti-inflammatory, antioxidant, and regenerative effects at the cellular level. 

This biocompatible formulation offers superior regenerative capabilities while maintaining an excellent safety profile for professional application. The sophisticated blend of bioactive components makes EXOJUV suitable for multiple skin concerns, from anti-aging treatments to post-procedural recovery protocols.

EXOJUV Dosage and Administration

Professional application of mesotherapy injections requires adherence to specific protocols. Standard treatment consists of 2-3 sessions spaced 4 weeks apart, utilizing 1-2 mL of reconstituted solution per session. EXOJUV can be administered through microneedling, mesotherapy injection, or dermal infusion techniques.

The freeze-dried exosomes require proper reconstitution using EXOJUV protocols using the provided activator solution under aseptic conditions. The application should occur within 24 hours post-reconstitution. Results become visible after 4-8 weeks, with maintenance treatments administered every 6-12 months, depending on the patient’s response.

Ingredient Information

EXOJUV contains bioactive components that contribute to its therapeutic efficacy. The primary active substance consists of 5 billion plant-derived exosomes from Asian Centella, providing growth factors and proteins essential for cellular renewal. The formulation includes an amino acid complex featuring sodium hyaluronate, glutathione, and niacinamide.

High-purity exosomes contain proteins, RNA, and growth factors, facilitating cellular communication and repair mechanisms. This composition enables EXOJUV to serve as an alternative to traditional dermal fillers, offering superior regeneration capabilities. The collagen-stimulating properties promote sustained skin improvement.

Storage Instructions

Proper storage maintains the potency and efficacy of EXOJUV. Store freeze-dried formulation at 2-8°C in refrigerated conditions before reconstitution. Avoid direct sunlight and excessive heat to preserve exosomes’ stability.

Once reconstituted, maintain optimal potency for 24 hours under appropriate conditions. Temperature fluctuations compromise the integrity of exosomes, potentially reducing treatment efficacy and outcomes.

EXOJUV Contraindications

Certain conditions preclude safe EXOJUV use. Contraindications include:

• Active infections or inflammatory skin diseases

• Autoimmune disorders affecting healing responses

• Pregnancy and breastfeeding periods

• History of severe allergic reactions to similar formulations

EXOJUV Precautions and Warnings

Safe application requires specific precautionary measures. Avoid intravascular injection and concurrent ablative laser treatments during healing phases. Professional administration is mandatory for optimal outcomes.

A complete medical history evaluation should precede treatment, with particular attention to previous dermal procedures and medications. Order tracking of treatment progress enables protocol adjustments and facilitates the identification of early adverse responses.

EXOJUV Manufacturer and Regulatory Information

EXOJUV is manufactured by Oreon Life Science under Good Manufacturing Practice (GMP) guidelines, ensuring adherence to high-quality and safety standards. Development incorporates advanced biotechnology and specialized research to optimize the stability and efficacy of exosomes.

The formulation complies with international regulatory standards and undergoes clinical testing to validate safety claims. Medical professionals can purchase EXOJUV online through authorized distributors, ensuring they receive authentic products. When practitioners order EXOJUV online, they receive verified products with complete documentation. Healthcare providers should purchase EXOJUV and order it from certified suppliers to ensure authenticity and efficacy.